These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22544896)

  • 1. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study.
    Tan WC; Vollmer WM; Lamprecht B; Mannino DM; Jithoo A; Nizankowska-Mogilnicka E; Mejza F; Gislason T; Burney PG; Buist AS;
    Thorax; 2012 Aug; 67(8):718-26. PubMed ID: 22544896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 3. Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV
    Quanjer PH; Ruppel GL; Langhammer A; Krishna A; Mertens F; Johannessen A; Menezes AMB; Wehrmeister FC; Perez-Padilla R; Swanney MP; Tan WC; Bourbeau J
    Chest; 2017 May; 151(5):1088-1098. PubMed ID: 28040521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
    Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
    Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
    Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
    Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
    [No Abstract]   [Full Text] [Related]  

  • 6. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease.
    Albert P; Agusti A; Edwards L; Tal-Singer R; Yates J; Bakke P; Celli BR; Coxson HO; Crim C; Lomas DA; Macnee W; Miller B; Rennard S; Silverman EK; Vestbo J; Wouters E; Calverley P
    Thorax; 2012 Aug; 67(8):701-8. PubMed ID: 22696176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?
    Bhatt NY; Wood KL
    Drugs Aging; 2008; 25(9):717-28. PubMed ID: 18729545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Fortis S; Quibrera PM; Comellas AP; Bhatt SP; Tashkin DP; Hoffman EA; Criner GJ; Han MK; Barr RG; Arjomandi M; Dransfield MB; Peters SP; Dolezal BA; Kim V; Putcha N; Rennard SI; Paine R; Kanner RE; Curtis JL; Bowler RP; Martinez FJ; Hansel NN; Krishnan JA; Woodruff PG; Barjaktarevic IZ; Couper D; Anderson WH; Cooper CB;
    Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study.
    Vollmer WM; Gíslason T; Burney P; Enright PL; Gulsvik A; Kocabas A; Buist AS
    Eur Respir J; 2009 Sep; 34(3):588-97. PubMed ID: 19460786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of bronchodilator response: utilizing pre-bronchodilator versus predicted normal values.
    Alexis A; Punjabi NM; Grealis K; Wanner A
    BMC Pulm Med; 2024 Jan; 24(1):54. PubMed ID: 38273287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD.
    Celli BR; Tashkin DP; Rennard SI; McElhattan J; Martin UJ
    Respir Med; 2011 Aug; 105(8):1176-88. PubMed ID: 21531124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.
    Li Y; Lin J; Wang Z; Wang Z; Tan L; Liu S; Huang J; Gao Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2623-2633. PubMed ID: 36274994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchodilator responsiveness and reported respiratory symptoms in an adult population.
    Tan WC; Bourbeau J; Hernandez P; Chapman KR; Cowie R; FitzGerald JM; Aaron S; Marciniuk DD; Maltais F; Buist AS; O'Donnell DE; Sin DD;
    PLoS One; 2013; 8(3):e58932. PubMed ID: 23554960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease.
    Palmer LJ; Celedón JC; Chapman HA; Speizer FE; Weiss ST; Silverman EK
    Hum Mol Genet; 2003 May; 12(10):1199-210. PubMed ID: 12719384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-bronchodilator spirometry reference values in adults and implications for disease management.
    Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow and volume response to bronchodilator in patients with COPD.
    Vigna M; Aiello M; Bertorelli G; Crisafulli E; Chetta A
    Acta Biomed; 2018 Oct; 89(3):332-336. PubMed ID: 30333454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the response to a bronchodilator in patients with airflow obstruction and lung cancer.
    Ueda K; Murakami J; Tanaka T; Yoshida K; Kobayashi T; Hamano K
    J Surg Res; 2018 Aug; 228():20-26. PubMed ID: 29907212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.